glp-1 weight loss news The FDA approved a new pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Obesity patients with other conditions

The neurological effects of these medications extend beyond simple appetite suppression, potentially offering therapeutic benefits for conditions affecting brain health

Calculate your exact dose using the peptide calculator to convert between milligrams, micrograms, and injection volumes based on your specific reconstitution

For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said

Tetrazole, a widely used heterocyclic core structure, serves as a frequent scaffold in drug design, often replacing carboxyl groups due to its resistance to metabolism

Consume the entire contents of one sachet (10ml), preferably at least 15 minutes before meals